|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,700.00 KRW | -3.29% |
|
+5.26% | -31.09% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/25/12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.29% | +5.26% | -47.95% | - | 7.41Cr | ||
| +0.08% | +6.39% | +71.70% | +469.05% | 3.96TCr | ||
| -0.89% | +7.48% | +10.10% | +37.02% | 2.33TCr | ||
| -0.29% | +5.34% | -21.71% | -41.19% | 715.33Cr | ||
| -2.52% | +13.91% | +22.84% | +115.99% | 516Cr | ||
| +1.68% | -0.58% | +18.98% | +46.08% | 285.43Cr | ||
| -0.29% | -1.88% | -24.96% | +1,040.10% | 212.89Cr | ||
| +2.91% | +9.76% | +103.65% | -4.50% | 194.93Cr | ||
| -0.93% | +6.06% | +35.58% | -20.76% | 184.38Cr | ||
| +1.88% | +1.55% | +20.23% | -3.74% | 161.44Cr | ||
| Average | -0.12% | +7.15% | +18.85% | +182.01% | 856.22Cr | |
| Weighted average by Cap. | +0.43% | +6.69% | +38.92% | +257.36% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















